細胞表面マーカー市場：製品タイプ、供給源、細胞タイプ、用途、エンドユーザー別-2025年～2030年の世界予測

細胞表面マーカー市場は、2023年に7億8,586万米ドルと評価され、2024年には8億5,827万米ドルに達すると予測され、CAGR 9.30%で成長し、2030年には14億6,518万米ドルに達すると予測されています。

細胞表面抗原としても知られる細胞表面マーカーは、細胞表面に位置する重要な分子であり、異なる細胞種の区別を可能にする識別子の役割を果たします。これらのマーカーは、細胞生物学および免疫学の分野において、特定の細胞集団を同定、分離、研究するために不可欠です。細胞表面マーカーの必要性は、腫瘍細胞を同定し標的とするがん研究など、医療診断、医薬品開発、治療応用における重要な役割に由来します。臨床環境では、これらのマーカーは診断や白血病やリンパ腫のような疾患のモニタリングに用いられています。

バイオテクノロジーと製薬産業の拡大、腫瘍学と幹細胞研究への投資の増加は、細胞表面マーカー市場の主要な成長要因です。フローサイトメトリーや質量分析技術の継続的な進歩も、細胞マーカー分析の精度と効率を高めることで市場の成長を後押ししています。個別化医療に新たな機会が生まれつつあり、オーダーメイドの治療戦略のために特定のマーカーを活用することは有望な成長機会となります。こうした機会を捉えるために、利害関係者は共同研究開発イニシアチブを促進し、先進技術を活用してコスト効率の高い迅速な診断ソリューションを開発することに注力すべきです。

しかし、新興経済諸国では技術コストが高く、熟練した専門家が不足しているため導入が遅れる可能性があるなど、市場開拓は課題に直面しています。さらに、地域によっては規制のハードルや倫理的な懸念が研究や応用の妨げになることもあります。このような課題にもかかわらず、希少疾患用の新規マーカーの開発、精度を高めるためのラベリング技術の改善、予測分析のためのバイオインフォマティクスの研究などの分野では、イノベーションが促進される可能性があります。

競合情勢が顕著な市場情勢では、継続的な研究とイノベーションが重視されます。事業の成長を目指す企業は、戦略的パートナーシップに注力し、特に高度なヘルスケアソリューションに対する需要が高いが入手可能な市場が限られている新興国市場を中心に、未開拓の市場を開拓すべきです。

市場力学：急速に進化する細胞表面マーカー市場の主要市場インサイトを公開

細胞表面マーカー市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • ヘルスケア、ライフサイエンス、製薬産業の拡大
  • 体外診断の採用ニーズの高まり
  • がんや自己免疫疾患の発生率の増加
• 市場抑制要因
  • 細胞研究活動に伴う高コスト
• 市場機会
  • 新薬上市のための研究開発投資の増加
  • ヘルスケア分野における技術進歩の高まり
• 市場の課題
  • 機器や厳しい規制遵守に伴う複雑さ

ポーターの5つの力：細胞表面マーカー市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：細胞表面マーカー市場における外部からの影響の把握

外部マクロ環境要因は、細胞表面マーカー市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析細胞表面マーカー市場における競合情勢の把握

細胞表面マーカー市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス細胞表面マーカー市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、細胞表面マーカー市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨細胞表面マーカー市場における成功への道筋を描く

細胞表面マーカー市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 拡大するヘルスケア、ライフサイエンス、製薬業界
    • 体外診断の導入ニーズの高まり
    • がんやその他の自己免疫疾患の発生率の増加
  • 抑制要因
    • 細胞調査活動に伴う高コスト
  • 機会
    • 新薬発売に向けた研究開発への投資増加
    • ヘルスケア分野における技術進歩の高まり
  • 課題
    • 機器に関連する複雑さと厳格な規制遵守
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 細胞表面マーカー市場：製品別

• 抗体
• PCRアレイ

第7章 細胞表面マーカー市場：供給源別

• マウス
• ネズミ

第8章 細胞表面マーカー市場：細胞タイプ別

• B細胞表面マーカー
• 単球細胞表面マーカー
• NK細胞表面マーカー
• T細胞表面マーカー

第9章 細胞表面マーカー市場：用途別

• 臨床
  • 免疫不全疾患
  • 腫瘍学
• 研究
  • 創薬
  • 免疫学
  • 幹細胞調査

第10章 細胞表面マーカー市場：エンドユーザー別

• 学術研究機関
• 病院および臨床検査研究所
• 製薬・バイオテクノロジー企業

第11章 南北アメリカの細胞表面マーカー市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第12章 アジア太平洋の細胞表面マーカー市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第13章 欧州・中東・アフリカの細胞表面マーカー市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第14章 競合情勢

• 市場シェア分析2023年
• FPNVポジショニングマトリックス、2023年
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Abbott Laboratories
• Abcam PLC
• Agilent Technologies, Inc.
• arigo Biolaboratories Corp.
• Becton, Dickinson and Company
• Bio-Rad Laboratories, Inc.
• Bio-Techne Corporation
• Cell Signaling Technology Inc.
• Creative Bioarray
• Creative Diagnostics
• Danaher Corporation
• F. Hoffmann-La Roche Ltd.
• GenScript Biotech Corporation
• Grifols SA
• Merck KGaA
• Nihon Kohden Corporation
• PerkinElmer Inc.
• Qiagen N.V.
• Qima Ltd.
• R&D Systems, Inc.
• ScienCell Research Laboratories, Inc.
• Siemens Healthineers AG
• Stemcell Technologies Inc.
• Sysmex Corporation
• Thermo Fisher Scientific Inc.

LIST OF FIGURES

• FIGURE 1. CELL SURFACE MARKERS MARKET RESEARCH PROCESS
• FIGURE 2. CELL SURFACE MARKERS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL CELL SURFACE MARKERS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY SOURCE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY SOURCE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY CELL TYPE, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY CELL TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 15. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. AMERICAS CELL SURFACE MARKERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. AMERICAS CELL SURFACE MARKERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. UNITED STATES CELL SURFACE MARKERS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 19. UNITED STATES CELL SURFACE MARKERS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. ASIA-PACIFIC CELL SURFACE MARKERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. ASIA-PACIFIC CELL SURFACE MARKERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CELL SURFACE MARKERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 23. EUROPE, MIDDLE EAST & AFRICA CELL SURFACE MARKERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 24. CELL SURFACE MARKERS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 25. CELL SURFACE MARKERS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. CELL SURFACE MARKERS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL CELL SURFACE MARKERS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. CELL SURFACE MARKERS MARKET DYNAMICS
• TABLE 7. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY PCR ARRAYS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY MICE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY RATS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY B CELL SURFACE MARKERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY MONOCYTE CELL SURFACE MARKERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY NK CELL SURFACE MARKERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY T CELL SURFACE MARKERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY CLINICAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY IMMUNODEFICIENCY DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY STEM CELL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY HOSPITALS & CLINICAL TESTING LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. AMERICAS CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 33. AMERICAS CELL SURFACE MARKERS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 34. AMERICAS CELL SURFACE MARKERS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 35. AMERICAS CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 36. AMERICAS CELL SURFACE MARKERS MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 37. AMERICAS CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
• TABLE 38. AMERICAS CELL SURFACE MARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 39. AMERICAS CELL SURFACE MARKERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 40. ARGENTINA CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 41. ARGENTINA CELL SURFACE MARKERS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 42. ARGENTINA CELL SURFACE MARKERS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 43. ARGENTINA CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 44. ARGENTINA CELL SURFACE MARKERS MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 45. ARGENTINA CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
• TABLE 46. ARGENTINA CELL SURFACE MARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 47. BRAZIL CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 48. BRAZIL CELL SURFACE MARKERS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 49. BRAZIL CELL SURFACE MARKERS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 50. BRAZIL CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 51. BRAZIL CELL SURFACE MARKERS MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 52. BRAZIL CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
• TABLE 53. BRAZIL CELL SURFACE MARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 54. CANADA CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 55. CANADA CELL SURFACE MARKERS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 56. CANADA CELL SURFACE MARKERS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 57. CANADA CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 58. CANADA CELL SURFACE MARKERS MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 59. CANADA CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
• TABLE 60. CANADA CELL SURFACE MARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 61. MEXICO CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 62. MEXICO CELL SURFACE MARKERS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 63. MEXICO CELL SURFACE MARKERS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 64. MEXICO CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 65. MEXICO CELL SURFACE MARKERS MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 66. MEXICO CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
• TABLE 67. MEXICO CELL SURFACE MARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 68. UNITED STATES CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 69. UNITED STATES CELL SURFACE MARKERS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 70. UNITED STATES CELL SURFACE MARKERS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 71. UNITED STATES CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 72. UNITED STATES CELL SURFACE MARKERS MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 73. UNITED STATES CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
• TABLE 74. UNITED STATES CELL SURFACE MARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 75. UNITED STATES CELL SURFACE MARKERS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 76. ASIA-PACIFIC CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 77. ASIA-PACIFIC CELL SURFACE MARKERS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 78. ASIA-PACIFIC CELL SURFACE MARKERS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 79. ASIA-PACIFIC CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 80. ASIA-PACIFIC CELL SURFACE MARKERS MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 81. ASIA-PACIFIC CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
• TABLE 82. ASIA-PACIFIC CELL SURFACE MARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 83. ASIA-PACIFIC CELL SURFACE MARKERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 84. AUSTRALIA CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 85. AUSTRALIA CELL SURFACE MARKERS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 86. AUSTRALIA CELL SURFACE MARKERS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 87. AUSTRALIA CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 88. AUSTRALIA CELL SURFACE MARKERS MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 89. AUSTRALIA CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
• TABLE 90. AUSTRALIA CELL SURFACE MARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 91. CHINA CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 92. CHINA CELL SURFACE MARKERS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 93. CHINA CELL SURFACE MARKERS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 94. CHINA CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 95. CHINA CELL SURFACE MARKERS MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 96. CHINA CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
• TABLE 97. CHINA CELL SURFACE MARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 98. INDIA CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 99. INDIA CELL SURFACE MARKERS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 100. INDIA CELL SURFACE MARKERS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 101. INDIA CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 102. INDIA CELL SURFACE MARKERS MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 103. INDIA CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
• TABLE 104. INDIA CELL SURFACE MARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 105. INDONESIA CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 106. INDONESIA CELL SURFACE MARKERS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 107. INDONESIA CELL SURFACE MARKERS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 108. INDONESIA CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 109. INDONESIA CELL SURFACE MARKERS MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 110. INDONESIA CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
• TABLE 111. INDONESIA CELL SURFACE MARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 112. JAPAN CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 113. JAPAN CELL SURFACE MARKERS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 114. JAPAN CELL SURFACE MARKERS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 115. JAPAN CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 116. JAPAN CELL SURFACE MARKERS MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 117. JAPAN CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
• TABLE 118. JAPAN CELL SURFACE MARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 119. MALAYSIA CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 120. MALAYSIA CELL SURFACE MARKERS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 121. MALAYSIA CELL SURFACE MARKERS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 122. MALAYSIA CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 123. MALAYSIA CELL SURFACE MARKERS MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 124. MALAYSIA CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
• TABLE 125. MALAYSIA CELL SURFACE MARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 126. PHILIPPINES CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 127. PHILIPPINES CELL SURFACE MARKERS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 128. PHILIPPINES CELL SURFACE MARKERS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 129. PHILIPPINES CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 130. PHILIPPINES CELL SURFACE MARKERS MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 131. PHILIPPINES CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
• TABLE 132. PHILIPPINES CELL SURFACE MARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 133. SINGAPORE CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 134. SINGAPORE CELL SURFACE MARKERS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 135. SINGAPORE CELL SURFACE MARKERS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 136. SINGAPORE CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 137. SINGAPORE CELL SURFACE MARKERS MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 138. SINGAPORE CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
• TABLE 139. SINGAPORE CELL SURFACE MARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 140. SOUTH KOREA CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 141. SOUTH KOREA CELL SURFACE MARKERS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 142. SOUTH KOREA CELL SURFACE MARKERS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 143. SOUTH KOREA CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 144. SOUTH KOREA CELL SURFACE MARKERS MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 145. SOUTH KOREA CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
• TABLE 146. SOUTH KOREA CELL SURFACE MARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 147. TAIWAN CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 148. TAIWAN CELL SURFACE MARKERS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 149. TAIWAN CELL SURFACE MARKERS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 150. TAIWAN CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 151. TAIWAN CELL SURFACE MARKERS MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 152. TAIWAN CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
• TABLE 153. TAIWAN CELL SURFACE MARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 154. THAILAND CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 155. THAILAND CELL SURFACE MARKERS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 156. THAILAND CELL SURFACE MARKERS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 157. THAILAND CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 158. THAILAND CELL SURFACE MARKERS MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 159. THAILAND CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
• TABLE 160. THAILAND CELL SURFACE MARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 161. VIETNAM CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 162. VIETNAM CELL SURFACE MARKERS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 163. VIETNAM CELL SURFACE MARKERS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 164. VIETNAM CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 165. VIETNAM CELL SURFACE MARKERS MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 166. VIETNAM CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
• TABLE 167. VIETNAM CELL SURFACE MARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 168. EUROPE, MIDDLE EAST & AFRICA CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 169. EUROPE, MIDDLE EAST & AFRICA CELL SURFACE MARKERS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 170. EUROPE, MIDDLE EAST & AFRICA CELL SURFACE MARKERS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 171. EUROPE, MIDDLE EAST & AFRICA CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 172. EUROPE, MIDDLE EAST & AFRICA CELL SURFACE MARKERS MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 173. EUROPE, MIDDLE EAST & AFRICA CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
• TABLE 174. EUROPE, MIDDLE EAST & AFRICA CELL SURFACE MARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 175. EUROPE, MIDDLE EAST & AFRICA CELL SURFACE MARKERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 176. DENMARK CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 177. DENMARK CELL SURFACE MARKERS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 178. DENMARK CELL SURFACE MARKERS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 179. DENMARK CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 180. DENMARK CELL SURFACE MARKERS MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 181. DENMARK CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
• TABLE 182. DENMARK CELL SURFACE MARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 183. EGYPT CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 184. EGYPT CELL SURFACE MARKERS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 185. EGYPT CELL SURFACE MARKERS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 186. EGYPT CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 187. EGYPT CELL SURFACE MARKERS MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 188. EGYPT CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
• TABLE 189. EGYPT CELL SURFACE MARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 190. FINLAND CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 191. FINLAND CELL SURFACE MARKERS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 192. FINLAND CELL SURFACE MARKERS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 193. FINLAND CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 194. FINLAND CELL SURFACE MARKERS MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 195. FINLAND CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
• TABLE 196. FINLAND CELL SURFACE MARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 197. FRANCE CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 198. FRANCE CELL SURFACE MARKERS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 199. FRANCE CELL SURFACE MARKERS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 200. FRANCE CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 201. FRANCE CELL SURFACE MARKERS MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 202. FRANCE CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
• TABLE 203. FRANCE CELL SURFACE MARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 204. GERMANY CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 205. GERMANY CELL SURFACE MARKERS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 206. GERMANY CELL SURFACE MARKERS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 207. GERMANY CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 208. GERMANY CELL SURFACE MARKERS MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 209. GERMANY CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
• TABLE 210. GERMANY CELL SURFACE MARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 211. ISRAEL CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 212. ISRAEL CELL SURFACE MARKERS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 213. ISRAEL CELL SURFACE MARKERS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 214. ISRAEL CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 215. ISRAEL CELL SURFACE MARKERS MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 216. ISRAEL CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
• TABLE 217. ISRAEL CELL SURFACE MARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 218. ITALY CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 219. ITALY CELL SURFACE MARKERS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 220. ITALY CELL SURFACE MARKERS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 221. ITALY CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 222. ITALY CELL SURFACE MARKERS MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 223. ITALY CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
• TABLE 224. ITALY CELL SURFACE MARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 225. NETHERLANDS CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 226. NETHERLANDS CELL SURFACE MARKERS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 227. NETHERLANDS CELL SURFACE MARKERS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 228. NETHERLANDS CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 229. NETHERLANDS CELL SURFACE MARKERS MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 230. NETHERLANDS CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
• TABLE 231. NETHERLANDS CELL SURFACE MARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 232. NIGERIA CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 233. NIGERIA CELL SURFACE MARKERS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 234. NIGERIA CELL SURFACE MARKERS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 235. NIGERIA CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 236. NIGERIA CELL SURFACE MARKERS MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 237. NIGERIA CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
• TABLE 238. NIGERIA CELL SURFACE MARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 239. NORWAY CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 240. NORWAY CELL SURFACE MARKERS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 241. NORWAY CELL SURFACE MARKERS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 242. NORWAY CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 243. NORWAY CELL SURFACE MARKERS MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 244. NORWAY CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
• TABLE 245. NORWAY CELL SURFACE MARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 246. POLAND CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 247. POLAND CELL SURFACE MARKERS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 248. POLAND CELL SURFACE MARKERS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 249. POLAND CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 250. POLAND CELL SURFACE MARKERS MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 251. POLAND CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
• TABLE 252. POLAND CELL SURFACE MARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 253. QATAR CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 254. QATAR CELL SURFACE MARKERS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 255. QATAR CELL SURFACE MARKERS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 256. QATAR CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 257. QATAR CELL SURFACE MARKERS MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 258. QATAR CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
• TABLE 259. QATAR CELL SURFACE MARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 260. RUSSIA CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 261. RUSSIA CELL SURFACE MARKERS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 262. RUSSIA CELL SURFACE MARKERS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 263. RUSSIA CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 264. RUSSIA CELL SURFACE MARKERS MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 265. RUSSIA CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
• TABLE 266. RUSSIA CELL SURFACE MARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 267. SAUDI ARABIA CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 268. SAUDI ARABIA CELL SURFACE MARKERS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 269. SAUDI ARABIA CELL SURFACE MARKERS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 270. SAUDI ARABIA CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 271. SAUDI ARABIA CELL SURFACE MARKERS MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 272. SAUDI ARABIA CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
• TABLE 273. SAUDI ARABIA CELL SURFACE MARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 274. SOUTH AFRICA CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 275. SOUTH AFRICA CELL SURFACE MARKERS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 276. SOUTH AFRICA CELL SURFACE MARKERS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 277. SOUTH AFRICA CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 278. SOUTH AFRICA CELL SURFACE MARKERS MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 279. SOUTH AFRICA CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
• TABLE 280. SOUTH AFRICA CELL SURFACE MARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 281. SPAIN CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 282. SPAIN CELL SURFACE MARKERS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 283. SPAIN CELL SURFACE MARKERS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 284. SPAIN CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 285. SPAIN CELL SURFACE MARKERS MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 286. SPAIN CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
• TABLE 287. SPAIN CELL SURFACE MARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 288. SWEDEN CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 289. SWEDEN CELL SURFACE MARKERS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 290. SWEDEN CELL SURFACE MARKERS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 291. SWEDEN CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 292. SWEDEN CELL SURFACE MARKERS MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 293. SWEDEN CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
• TABLE 294. SWEDEN CELL SURFACE MARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 295. SWITZERLAND CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 296. SWITZERLAND CELL SURFACE MARKERS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 297. SWITZERLAND CELL SURFACE MARKERS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 298. SWITZERLAND CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 299. SWITZERLAND CELL SURFACE MARKERS MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 300. SWITZERLAND CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
• TABLE 301. SWITZERLAND CELL SURFACE MARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 302. TURKEY CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 303. TURKEY CELL SURFACE MARKERS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 304. TURKEY CELL SURFACE MARKERS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 305. TURKEY CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 306. TURKEY CELL SURFACE MARKERS MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 307. TURKEY CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
• TABLE 308. TURKEY CELL SURFACE MARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 309. UNITED ARAB EMIRATES CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 310. UNITED ARAB EMIRATES CELL SURFACE MARKERS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 311. UNITED ARAB EMIRATES CELL SURFACE MARKERS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 312. UNITED ARAB EMIRATES CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 313. UNITED ARAB EMIRATES CELL SURFACE MARKERS MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 314. UNITED ARAB EMIRATES CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
• TABLE 315. UNITED ARAB EMIRATES CELL SURFACE MARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 316. UNITED KINGDOM CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 317. UNITED KINGDOM CELL SURFACE MARKERS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 318. UNITED KINGDOM CELL SURFACE MARKERS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
• TABLE 319. UNITED KINGDOM CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 320. UNITED KINGDOM CELL SURFACE MARKERS MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 321. UNITED KINGDOM CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
• TABLE 322. UNITED KINGDOM CELL SURFACE MARKERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 323. CELL SURFACE MARKERS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 324. CELL SURFACE MARKERS MARKET, FPNV POSITIONING MATRIX, 2023

The Cell Surface Markers Market was valued at USD 785.86 million in 2023, expected to reach USD 858.27 million in 2024, and is projected to grow at a CAGR of 9.30%, to USD 1,465.18 million by 2030.

Cell surface markers, also known as cell surface antigens, are crucial molecules located on the surface of cells that serve as identifiers enabling the distinction between different cell types. These markers are integral in the field of cell biology and immunology for identifying, isolating, and studying specific cell populations. The necessity of cell surface markers stems from their vital role in medical diagnostics, drug development, and therapeutic applications, such as in cancer research for identifying and targeting tumor cells. In clinical environments, these markers are employed in diagnostics and the monitoring of diseases like leukemia and lymphoma.

The expanding scope of biotechnology and pharmaceutical industries, along with increasing investments in oncology and stem cell research, are key growth influencers for the cell surface markers market. Continuing advancements in flow cytometry and mass spectrometry technologies are also bolstering market growth by enhancing the accuracy and efficiency of cell marker analysis. Opportunities are emerging in personalized medicine; leveraging specific markers for tailored treatment strategies offers a promising growth avenue. To seize these opportunities, industry stakeholders should focus on fostering collaborative R&D initiatives and leveraging advanced technologies to develop cost-effective and rapid diagnostic solutions.

However, market growth faces challenges, such as high costs of technologies and a lack of skilled professionals in developing economies, which may slow adoption. Moreover, regulatory hurdles and ethical concerns in some regions can impede research and application. Despite these challenges, innovation can thrive in areas such as the development of novel markers for rare diseases, improving labeling technologies for better accuracy, and research in bioinformatics for predictive analysis.

The cell surface markers market is marked by a competitive landscape, emphasizing continuous research and innovation. Companies aiming for business growth should focus on strategic partnerships and explore unexplored markets, particularly in developing nations, where there is a high demand for advanced healthcare solutions but limited availability.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cell Surface Markers Market

The Cell Surface Markers Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Expanding healthcare, life sciences, and pharmaceutical industries
  • Rising need for adoption of in vitro diagnostics
  • Growing occurrence rate of cancer and other autoimmune diseases
• Market Restraints
  • High costs associated with cell research activities
• Market Opportunities
  • Growing investment in research and development to launch new drugs
  • Rising technological advancement in the healthcare sector
• Market Challenges
  • Complexities associated with instruments and stringent regulatory compliances

Porter's Five Forces: A Strategic Tool for Navigating the Cell Surface Markers Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cell Surface Markers Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cell Surface Markers Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cell Surface Markers Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cell Surface Markers Market

A detailed market share analysis in the Cell Surface Markers Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cell Surface Markers Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cell Surface Markers Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cell Surface Markers Market

A strategic analysis of the Cell Surface Markers Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cell Surface Markers Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Abcam PLC, Agilent Technologies, Inc., arigo Biolaboratories Corp., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, Cell Signaling Technology Inc., Creative Bioarray, Creative Diagnostics, Danaher Corporation, F. Hoffmann-La Roche Ltd., GenScript Biotech Corporation, Grifols SA, Merck KGaA, Nihon Kohden Corporation, PerkinElmer Inc., Qiagen N.V., Qima Ltd., R&D Systems, Inc., ScienCell Research Laboratories, Inc., Siemens Healthineers AG, Stemcell Technologies Inc., Sysmex Corporation, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Cell Surface Markers Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Antibodies and PCR Arrays.
• Based on Source, market is studied across Mice and Rats.
• Based on Cell Type, market is studied across B Cell Surface Markers, Monocyte Cell Surface Markers, NK Cell Surface Markers, and T Cell Surface Markers.
• Based on Application, market is studied across Clinical and Research. The Clinical is further studied across Immunodeficiency Diseases and Oncology. The Research is further studied across Drug Discovery, Immunology, and Stem Cell Research.
• Based on End-User, market is studied across Academic & Research Institutes, Hospitals & Clinical Testing Laboratories, and Pharmaceutical & Biotechnology Companies.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Expanding healthcare, life sciences, and pharmaceutical industries
    • 5.1.1.2. Rising need for adoption of in vitro diagnostics
    • 5.1.1.3. Growing occurrence rate of cancer and other autoimmune diseases
  • 5.1.2. Restraints
    • 5.1.2.1. High costs associated with cell research activities
  • 5.1.3. Opportunities
    • 5.1.3.1. Growing investment in research and development to launch new drugs
    • 5.1.3.2. Rising technological advancement in the healthcare sector
  • 5.1.4. Challenges
    • 5.1.4.1. Complexities associated with instruments and stringent regulatory compliances
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Cell Surface Markers Market, by Product

• 6.1. Introduction
• 6.2. Antibodies
• 6.3. PCR Arrays

7. Cell Surface Markers Market, by Source

• 7.1. Introduction
• 7.2. Mice
• 7.3. Rats

8. Cell Surface Markers Market, by Cell Type

• 8.1. Introduction
• 8.2. B Cell Surface Markers
• 8.3. Monocyte Cell Surface Markers
• 8.4. NK Cell Surface Markers
• 8.5. T Cell Surface Markers

9. Cell Surface Markers Market, by Application

• 9.1. Introduction
• 9.2. Clinical
  • 9.2.1. Immunodeficiency Diseases
  • 9.2.2. Oncology
• 9.3. Research
  • 9.3.1. Drug Discovery
  • 9.3.2. Immunology
  • 9.3.3. Stem Cell Research

10. Cell Surface Markers Market, by End-User

• 10.1. Introduction
• 10.2. Academic & Research Institutes
• 10.3. Hospitals & Clinical Testing Laboratories
• 10.4. Pharmaceutical & Biotechnology Companies

11. Americas Cell Surface Markers Market

• 11.1. Introduction
• 11.2. Argentina
• 11.3. Brazil
• 11.4. Canada
• 11.5. Mexico
• 11.6. United States

12. Asia-Pacific Cell Surface Markers Market

• 12.1. Introduction
• 12.2. Australia
• 12.3. China
• 12.4. India
• 12.5. Indonesia
• 12.6. Japan
• 12.7. Malaysia
• 12.8. Philippines
• 12.9. Singapore
• 12.10. South Korea
• 12.11. Taiwan
• 12.12. Thailand
• 12.13. Vietnam

13. Europe, Middle East & Africa Cell Surface Markers Market

• 13.1. Introduction
• 13.2. Denmark
• 13.3. Egypt
• 13.4. Finland
• 13.5. France
• 13.6. Germany
• 13.7. Israel
• 13.8. Italy
• 13.9. Netherlands
• 13.10. Nigeria
• 13.11. Norway
• 13.12. Poland
• 13.13. Qatar
• 13.14. Russia
• 13.15. Saudi Arabia
• 13.16. South Africa
• 13.17. Spain
• 13.18. Sweden
• 13.19. Switzerland
• 13.20. Turkey
• 13.21. United Arab Emirates
• 13.22. United Kingdom

14. Competitive Landscape

• 14.1. Market Share Analysis, 2023
• 14.2. FPNV Positioning Matrix, 2023
• 14.3. Competitive Scenario Analysis
• 14.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. Abcam PLC
• 3. Agilent Technologies, Inc.
• 4. arigo Biolaboratories Corp.
• 5. Becton, Dickinson and Company
• 6. Bio-Rad Laboratories, Inc.
• 7. Bio-Techne Corporation
• 8. Cell Signaling Technology Inc.
• 9. Creative Bioarray
• 10. Creative Diagnostics
• 11. Danaher Corporation
• 12. F. Hoffmann-La Roche Ltd.
• 13. GenScript Biotech Corporation
• 14. Grifols SA
• 15. Merck KGaA
• 16. Nihon Kohden Corporation
• 17. PerkinElmer Inc.
• 18. Qiagen N.V.
• 19. Qima Ltd.
• 20. R&D Systems, Inc.
• 21. ScienCell Research Laboratories, Inc.
• 22. Siemens Healthineers AG
• 23. Stemcell Technologies Inc.
• 24. Sysmex Corporation
• 25. Thermo Fisher Scientific Inc.